[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Apogee Therapeutics, Inc. Common Stock (APGE)
Deutsche Bank initiates coverage on Apogee Therapeutics (APGE) with a Buy rating and a $XXX price target, highlighting its potential in I&I diseases. The stock is seeing increased social media attention following this positive analyst coverage.
About Apogee Therapeutics, Inc. Common Stock
Apogee Therapeutics, Inc. Common Stock (APGE) is a publicly traded stock in the healthcare sector focused on developing biologic drugs.
Apogee Therapeutics, Inc. Common Stock uses the ticker $APGE for trading. Listed in the Stocks category.
Insights
- Apogee Therapeutics, Inc. Common Stock (APGE) trading volume is up XXXXX% from the previous week.
- Apogee Therapeutics, Inc. Common Stock (APGE) creators is up XXXXX% from the previous week.
- Apogee Therapeutics, Inc. Common Stock (APGE) mentions is up XXXXX% from the previous week.
- Apogee Therapeutics, Inc. Common Stock Price hit a 52-Week high of $XXXXX for the hour
- Apogee Therapeutics, Inc. Common Stock Price hit an all time of $XXXXX for the hour
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price has hit a 52-week high, supported by positive analyst ratings and strong investor confidence following a recent public offering. Initial price drops were short-lived, indicating robust demand and positive sentiment around its eczema drug pipeline.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXXX%
1-Year High: $XXXXX on 2025-12-05
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Apogee Therapeutics, Inc. Common Stock (APGE) is currently AltRank #1,017 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX -XXX
X Month: XXXXX +50
X Months: XXXXX +793
X Year: XXXXX -XXX
1-Year High: XXXXX on 2025-09-19
1-Year Low: XX on 2025-02-17
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-10-08
1-Year Low: XX on 2025-02-11
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +2.50%
X Month: XXXXXXX +12%
X Months: XXXXXXXXX +135%
X Year: XXXXXXXXX +83%
1-Year High: XXXXXXX on 2025-07-07
1-Year Low: XXX on 2025-10-26
Engagements by network (24h): TikTok: X X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +30%
X Month: XXX -XXXX%
X Months: XXXXX +163%
X Year: XXXXX +151%
1-Year High: XXX on 2025-07-07
1-Year Low: XX on 2025-09-06
Mentions by network (24h): TikTok: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Apogee Therapeutics, Inc. Common Stock (APGE) in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX +54%
X Month: XXX -XXXX%
X Months: XXXXX +358%
X Year: XXXXX +193%
1-Year High: XXX on 2025-07-07
1-Year Low: X on 2025-09-06
The most influential creators that mention Apogee Therapeutics, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedytx19 | X | XXXXX | X | XXX |
| @lee_WithDajuice | X | XXXXX | X | XX |
| @SteveDJacobs | X | XXXXX | X | X |
| @Market_Mentor01 | X | XX | X | X |
| @Trader_House04 | X | XX | X | X |
| @Skwld69988 | X | X | X | X |
| @Evie71425 | X | XX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-02-03
1-Year Low: X% on 2025-01-28
Most Supportive Themes:
- Analyst Ratings: (35%) Analysts are reiterating 'Buy' ratings and providing positive price targets for APGE.
- Public Offering Success: (25%) The closing of a public offering and the exercise of the underwriters' option to purchase additional shares have been met with positive reactions.
- Eczema Drug Potential: (20%) APGE's eczema drugs are highlighted as potential rivals to Dupixent, generating significant interest.
Most Critical Themes:
- Initial Price Drop Post-Offering: (10%) The public offering, while closed, initially caused a price drop, indicating some investor concern.
- Price Decrease Post-Offering Announcement: (10%) The stock experienced a price decrease after the announcement of the public offering, which may be a concern for some investors.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% -XXXXXX%
X Month: XXXXX% +0.013%
X Months: XXXXX% +0.014%
X Year: XXXXX% +0.0087%
1-Year High: XXXXX% on 2025-07-07
1-Year Low: XXXXXX% on 2025-09-06
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-12-05
1-Year Low: XXXXXXX% on 2025-02-27
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$1.40%
X Month: $XXXXXXXXXXXXX +$22%
X Months: $XXXXXXXXXXXXX +$102%
X Year: $XXXXXXXXXXXXX +$88%
1-Year High: $XXXXXXXXXXXXX on 2025-12-05
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top Apogee Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$APGE $AUR ⚠👀 Guys Don't miss the next move in a few hours 💸➡"
X Link @KallolKalo88348 2025-12-11T19:55Z XX followers, XX engagements
"On deck: $BLFY $CTS $PETS $ACIU $JZXN $ODYS $BTTC $NXDR $APGE $AVGO $NVDA 🎯 Key Focus: Keep close eye on $NXDR: $NXDR is still acting like it wants to fill that gap down from last week. Watching volume at the open like a hawk could see a sharp move"
X Link @JustinMorganQ8 2025-12-11T15:48Z XXX followers, XX engagements
"Tech & clean energy watchlist: $BLFY $CTS $PETS $ACIU $JZXN $ODYS $BTTC $NXDR $APGE $AVGO $NVDA $GOOG $GOOGL Key levels holding firm: $NXDR above insert level & $APGE above insert level = risk-on mode engaged. Eyes on that XXX SPX break momentum could accelerate fast"
X Link @jordanMaxwell37 2025-12-11T15:47Z 1106 followers, XX engagements
"Screen: $BLFY $CTS $PETS $ACIU $JZXN $ODYS $BTTC $NXDR $APGE Clean energy and tech are leading the charge ⚡ If $NVDA and $CTS hold we keep the momentum. If they falter buckle up it could get messy. Live sizing in playeyes on the key levels"
X Link @JesseWhitman09 2025-12-11T15:45Z 1657 followers, XX engagements